HDL Therapeutics Secures $2,045,000 Series B Funding Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d76583e9-1bac-4df9-8b73-efb4f3663874 Date 12/31/2014 Company Name HDL Therapeutics Mailing Address 46701 Commerce Center Drive Plymouth, MI 48170 USA Company Description The company is developing various biotechnologies. Website Undisclosed Transaction Type Venture Equity Transaction Amount $2,045,000 Transaction Round Series B Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. M&A Terms Venture Investor